menu
    • menu

    Company profile for Quantum Genomics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Quantum Genomics is a biopharmaceutical company specializing in the development of a new drug class for unmet medical needs in cardiovascular disease, including high blood pressure and heart failure. Quantum Genomics research programs are based on the brain inhibition mechanism of Aminopeptidase A : BAPAI (Brain Aminopeptidase A Inhibitors), a truly innovative triple-action therapeutic platform developed by the academic resear...
    Quantum Genomics is a biopharmaceutical company specializing in the development of a new drug class for unmet medical needs in cardiovascular disease, including high blood pressure and heart failure. Quantum Genomics research programs are based on the brain inhibition mechanism of Aminopeptidase A : BAPAI (Brain Aminopeptidase A Inhibitors), a truly innovative triple-action therapeutic platform developed by the academic research laboratories of the Collège de France and INSERM. Quantum Genomics is the only biopharmaceutical company specializing in the development of a new drug class based on the central action mechanism of Aminopeptidase.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Quantum GenomicsFrance Flag
    Country
    Country
    France
    Address
    Address
    33 rue Marbeuf 75008 Paris
    Telephone
    Telephone
    +33(0)1 85 34 77 70
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://quantum-genomics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fallout from Quantum Genomics' phase 3 fail claims executives
    Fallout from Quantum Genomics' phase 3 fail claims executives

    22 Feb 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fallout-quantum-genomics-phase-3-fail-claims-top-executives-biotech-searches-future

    Annalee Armstrong FIERCE BIOTECH
    22 Feb 2023
    Share Share
    Quantum Genomics Announces the Publication of New Scientific Article
    Quantum Genomics Announces the Publication of New Scientific Article

    18 May 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/05/19/2232760/0/en/Quantum-Genomics-Announces-the-Publication-of-New-Scientific-Article-in-Biomedicine-Pharmacotherapy-Which-Further-Strengthens-its-Phase-III-Development-Plan-in-Difficult-to-Treat-a.html

    GLOBENEWSWIRE
    18 May 2021
    Share Share
    Quantum Genomics Will Present Top-line Results From its QUORUM of Firibastat
    Quantum Genomics Will Present Top-line Results From its QUORUM of Firibastat

    21 Apr 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/04/21/2213820/0/en/Quantum-Genomics-Will-Present-Top-line-Results-From-its-QUORUM-Study-of-Firibastat-in-Heart-Failure-Post-Myocardial-Infarction-at-the-European-Society-of-Cardiology-ESC-Meeting.html#:~:text=PARIS%2C%20April%2021%2C%202021%20(,top%2Dline%20results%20from%20its

    GLOBENEWSWIRE
    21 Apr 2021
    Share Share
    Quantum Genomics Announces the End of its Collaboration with Qilu
    Quantum Genomics Announces the End of its Collaboration with Qilu

    20 Apr 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/04/20/2212887/0/en/Quantum-Genomics-Announces-the-End-of-its-Collaboration-with-Qilu-for-the-Development-and-Commercialization-of-Firibastat-in-China.html

    GLOBENEWSWIRE
    20 Apr 2021
    Share Share
    Quantum Genomics Launches Phase III Pivotal REFRESH Study Firibastat
    Quantum Genomics Launches Phase III Pivotal REFRESH Study Firibastat

    19 Jan 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/01/18/2160169/0/en/Quantum-Genomics-Launches-Phase-III-Pivotal-REFRESH-Study-in-Difficult-to-treat-Resistant-Hypertension-with-Once-a-day-Formulation-of-Firibastat.html

    GLOBENEWSWIRE
    19 Jan 2021
    Share Share
    Quantum Genomics Launches Phase III Pivotal REFRESH Study in Difficult
    Quantum Genomics Launches Phase III Pivotal REFRESH Study in Difficult

    18 Jan 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/01/18/2160169/0/en/Quantum-Genomics-Launches-Phase-III-Pivotal-REFRESH-Study-in-Difficult-to-treat-Resistant-Hypertension-with-Once-a-day-Formulation-of-Firibastat.html

    GLOBENEWSWIRE
    18 Jan 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search